VI
PTCT icon

Vestcor Inc’s PTC Therapeutics PTCT Stock Holding History

Vestcor Inc’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Buy
19,488
+6,471
+50% +$458K 0.04% 423
2025
Q4 		$989K Hold
13,017
– – 0.03% 495
2025
Q3 		$799K Buy
13,017
+8,143
+167% +$424K 0.02% 566
2025
Q2 		$238K Buy
+4,874
New +$231K 0.01% 928

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vestcor Inc's PTCT Position: Q1 2026 in Review

Vestcor Inc increased its PTC Therapeutics (PTCT) stake by 50% in Q1 2026, buying an estimated $458K and bringing the position to 19,488 shares worth $1.33M. The position accounts for 0.04% of the portfolio, ranked #423.

Vestcor Inc first reported a position in PTCT in Q2 2025 and has held it in 4 quarters since. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Vestcor Inc held 19,488 shares of PTC Therapeutics worth $1.33M as of Q1 2026.
  • Vestcor Inc bought 6,471 PTC Therapeutics shares in Q1 2026, an estimated $458K.
  • PTC Therapeutics made up 0.04% of Vestcor Inc's portfolio in Q1 2026, its #423 holding.
  • Vestcor Inc first reported a position in PTC Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.